James C. Czirr, Director, 10% Owner at GALECTIN THERAPEUTICS INC (GALT), sold 27,500 shares at $4.47 ($109K) on 2021-04-26, disclosed to the SEC on 2021-05-04.
Scheduled sale ($109k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.52 | 5,000 | $18K | 16.1% |
| 2 | $3.95 | 5,000 | $20K | 18.1% |
| 3 | $4.47 | 7,500 | $34K | 30.7% |
| 4 | $3.84 | 10,000 | $38K | 35.1% |
| Total | $3.97 avg | 27,500 | $109K | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-04-05 | $22K | — | Filing → |